Stem definition | Drug id | CAS RN |
---|---|---|
interleukin-2 analogues and derivatives | 5087 | 173146-27-5 |
Molecule | Description |
---|---|
Synonyms:
|
more potent, truncated form of DAB(486)-IL-2; inhibit HIV-1 RNA production in infected cells
|
None
None
Date | Agency | Company | Orphan |
---|---|---|---|
Feb. 5, 1999 | FDA | EISAI INC | |
March 23, 2021 | PMDA | Eisai Co., Ltd. |
None
None
None
None
Source | Code | Description |
---|---|---|
ATC | L01XX29 | ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS Other antineoplastic agents |
FDA CS | M0006522 | Diphtheria Toxin |
FDA CS | M0011506 | Interleukin-2 |
FDA CS | M0018640 | Recombinant Fusion Proteins |
MeSH PA | D000970 | Antineoplastic Agents |
FDA EPC | N0000177912 | CD25-directed Cytotoxin |
Disease | Relation | SNOMED_ID | DOID |
---|---|---|---|
Refractory peripheral T-cell lymphoma | indication | 109977009 | |
Primary cutaneous T-cell lymphoma | indication | 400122007 |
None
None
None
None
None
Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
---|---|---|---|---|---|---|---|---|---|
Interleukin-2 receptor | Membrane receptor | ANTIBODY BINDING | DRUG LABEL | DRUG LABEL |
ID | Source |
---|---|
25E79B5CTM | UNII |
D03682 | KEGG_DRUG |
C0717670 | UMLSCUI |
CHEMBL1201550 | ChEMBL_ID |
DB00004 | DRUGBANK_ID |
7680 | INN_ID |
C078456 | MESH_SUPPLEMENTAL_RECORD_UI |
7044 | IUPHAR_LIGAND_ID |
214470 | RXNORM |
14092 | MMSL |
7958 | MMSL |
d04386 | MMSL |
007748 | NDDF |
125700002 | SNOMEDCT_US |
398881002 | SNOMEDCT_US |
None